Clinical Trials in Minneapolis

Showing 3401-3420 of 9,155 trials

Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers

NCT04874233

This is a Phase 2a, randomized, parallel-group, placebo-controlled, double-blind, repeated-dose study to evaluate the safety and efficacy of three oral dose levels of HU6 compared to placebo over the course of 61 days in subjects with high BMI and evidence of elevated liver fat.

NASH - Nonalcoholic Steatohepatitis

Rivus Pharmaceuticals, Inc.80 participantsStarted Apr 2021

Minneapolis, Minnesota, United States

COMPLETED< 1 mile

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

NCT01474811

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Hepatitis C

University of North Carolina, Chapel Hill13,559 participantsStarted Nov 2011

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +57 more locations

Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Find Trials by Condition in Minneapolis

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

OCS Lung System EXPAND II Trial

Fetoscopic Endoluminal Tracheal Occlusion

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study

Medication Adherence Clinical Decision Support

Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Pilot Prospective Study: Long-term Health of Living Kidney Donors

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

Cardionomic STOP-ADHF Study

Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

A Clinical Trial of PRAX-944 in Participants With Essential Tremor